The activity of differentiation factors induces apoptosis in polyomavirus large T-expressing myoblasts

Molecular Biology of the Cell

Volumn 9, Issue 6, 1998, Pages 1449-1463

  Fimia, Gian Maria ^a,b   Gottifredi, Vanesa ^a   Bellei, Barbara ^a   Ricciardi, Maria Rosaria ^a   Tafuri, Agostino ^a   Amati, Paolo ^a   Maione, Rossella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS LARGE T ANTIGEN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; MOUSE; MYOBLAST; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

ANIMALIA; POLYOMAVIRUS;

EID: 0031869654     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.9.6.1449     Document Type: Article

References (78)

1. Almasan, A., Yin, Y., Kelly, R.E., Lee, E.Y., Bradley, A., W. Li, W., Bertino, J.R., and Wahl, G.M. (1995). Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 92, 5436-5440.
2. Bader, D., Masaki, T., and Fischman, D.A. (1982). Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95, 763-770.
3. Barres, B.A., Hart, I.K., Coles, H.S., Burne, J.F., Voyvodic, J.T., Richardson, W.D., and Raff, M.C. (1992). Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70, 31-46.
4. Baserga, R. (1994). Oncogenes and the strategy of growth factors. Cell 79, 927-930.
5. Bhatia, U., Traganos, F., and Darzynkiewicz, Z. (1995). Induction of cell differentiation potentiates apoptosis triggered by prior exposure to DNA-damaging drugs. Cell Growth Differ. 6, 937-944.
6. Bursch, W., Oberhammer, F., Jirtle, R.L., Askari, M., Sedivy, R., Grasl-Kraupp, B., Purchio, A.F., and Schulte-Hermann, R. (1993). Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br. J. Cancer 67, 531-536.
7. Caruso, M., Martelli, F., Giordano, A., and Felsani, A. (1993). Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein. Oncogene 8, 267-278.
8. Clarke, A.R., Maandag, E.R., van Roon, M., van der Lugt, N.M., van der Valk, M., Hooper, M.L., Berns, A., and te Riele, H. (1992). Requirement for a functional Rb-1 gene in murine development [see comments]. Nature 359, 328-330.
9. Crescenzi, M., Fleming, T.P., Lassar, A.B., Weintraub, H., and Aaronson, S.A. (1990). MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl. Acad. Sci. U.S.A. 87, 8442-8446.
10. Darzynkiewicz Z., Bruno, S., Del Bino, G., Gorezyca, W., Hotz, M.A., Lassota, P., and Traganos, F. (1992). Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795-808.
11. Davis, R.L., Cheng, P.F., Lassar, A.B., and Weintraub, H. (1990). The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell 60, 733-746.
12. Debbas, M., and White, E. (1993). Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes. Dev. 7, 546-554.
13. DeGregori, J., Kowalik, T., and Nevins, J.R. (1995). Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes Mol. Cell Biol. 15, 4215-4224. [erratum published in Mol. Cell Biol. 10, 5846-5847, Oct 15, 1995].
14. Eckner, R., Yao, T.P., Oldread, E., and Livingston, D.M. (1996). Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes. Dev. 10, 2478-2490.
15. Ellis, R.E., Yuan, J.Y., and Horvitz, H.R. (1991). Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663-698.
16. Endo, T., and Nadal-Ginard, B. (1986). Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype. Mol. Cell Biol. 6, 1412-1421.
17. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z., and Hancock, D.C. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128.
18. Fimia, G.M., Gottifredi, V., Passananti, C., and Maione, R. (1996). Double-stranded internucleosomal cleavage of apoptotic DNA is dependent on the degree of differentiation in muscle cells. J. Biol. Chem. 271, 15575-15579.
19. Florini, J.R., and Magri, K.A. (1989). Effects of growth factors on myogenic differentiation. Am. J. Physiol. 256, C701-C711.
20. Freund, R., Bauer, P.H., Crissman, H.A., Bradbury, E.M., and Benjamin, T.L. (1994). Host range and cell cycle activation properties of polyomavirus large T-antigen mutants defective in pRB binding. J. Virol. 68, 7227-7234.
21. Gu, W., Schneider, J.W., Condorelli, G., Kaushal, S., Mahdavi, V., and Nadal Ginard, B. (1993). Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72, 309-324.
22. Guo, K., Wang, J., Andres, V., Smith, R.C., and Walsh, K. (1995). MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell Biol. 15, 3823-3829.
23. Haas-Kogan, D.A., Kogan, S.C., Levi, D., Dazin P., T'Ang, A., Fung, Y.K., and Israel, M. A. (1995). Inhibition of apoptosis by the retinoblastoma gene product. EMBO. J. 24, 461-472.
24. Halevy, O., Novitch, B.G., Spicer, D.B., Skapek, S.X., Rhee, J., Hannon, G.J., Beach, D., and Lassar, A.B. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD [see comments]. Science 267, 1018-1021.
25. Harrington, E.A., Bennett, M.R., Fanidi, A., and Evan, G.I. (1994). c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO. J. 23, 3286-3295.
26. Holman, P.S., Gjoerup, O.V., Davin, T., and Schaffhausen, B.S. (1994). Characterization of an immortalizing N-terminal domain of polyomavirus large T antigen. J. Virol. 68, 668-673.
27. Ishizaki, Y., Cheng, L., Mudge, A.W., and Raff, M.C. (1995). Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells. Mol. Biol. Cell 6, 1443-1458.
28. Jacks, T., Fazeli, A., Schmitt, E.M., Bronson, R.T., Goodell, M.A., and Weinberg, R.A. (1992). Effects of an Rb mutation in the mouse [see comments]. Nature 359, 295-300.
29. Jacobson, M.D., Weil, M., and Raff, M.C. (1997). Programmed cell death in animal development. Cell 88, 347-354.
30. Ko, L.J., and Prives, C. (1996). p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
31. Kowalik, T.F., DeGregori, J., Schwarz, J.K., and Nevins, J.R. (1995). E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69, 2491-2500.
32. Kranenburg, O., van der Eb, A.J., and Zantema, A. (1996). Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO. J. 15, 46-54.
33. Larose, A., Dyson, N., Sullivan, M., Harlow, E., and Bastin, M. (1991). Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization. J. Virol. 65, 2308-2313.
34. Lassar, A.B., Thayer, M.J., Overell, R.W., and Weintraub, H. (1989). Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell 58, 659-667.
35. Lee, E.Y., Chang, C.Y., Hu, N., Wang, Y.C., Lai, C.C., Herrup, K., Lee, W.H., and Bradley, A. (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis [see comments]. Nature 359, 288-294.
36. Lee, E.Y., Hu, N., Yuan, S.S., Cox, L.A., Bradley, A., Lee, W.H., and Herrup, K. (1994). Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes. Dev. 8, 2008-2021.
37. Lemoli, R.M. et al. (1997). Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood 89, 1189-1196.
38. Levine, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
39. Li, H., and Capetanaki, Y. (1993). Regulation of the mouse desmin gene: transactivated by MyoD, myogenin, MRF4 and Myf5. Nucleic Acids Res. 21, 335-343.
40. Li, L., Zhou, J., James, G., Heller Harrison, R., Czech, M.P., and Olson, E.N. (1992). FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71, 1181-1194.
41. Lockshin, R.A., Knight, R.A., and Melino, J. (1995). Cell death in muscle pathology. Cell Death Differ. 2, 231-232.
42. Lowe, S.W., and Ruley, H.E. (1993). Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7, 535-545.
43. Maione, R., and Amati, P. (1997). Interdependence between muscle differentiation and cell-cycle control. Biochim. Biophys. Acta. 1332, M19-M30.
44. Maione, R., Fimia, G.M., and Amati, P. (1992a). Inhibition of in vitro muscle differentiation by the immortalizing oncogene py LT-ag. Symp. Soc. Exp. Biol. 46, 53-71.
45. Maione, R., Fimia, G.M., and Amati, P. (1992b). Inhibition of in vitro myogenic differentiation by a polyomavirus early function. Oncogene 7, 85-93.
46. Maione, R., Fimia, G.M., Holman, P., Schaffhausen, B., and Amati, P. (1994). Retinoblastoma antioncogene is involved in the inhibition of myogenesis by polyomavirus large T antigen. Cell Growth Differ. 5, 231-237.
47. Martelli, F., Cenciarelli, C., Santarelli, G., Polikar, B., Felsani, A., and Caruso, M. (1994). MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene 9, 3579-3590.
48. Morgenbesser, S.D., Williams, B.O., Jacks, T., and DePinho, R.A. (1994). p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens [see comments]. Nature 371, 72-74.
49. Morgenstern, J.P., and Land, H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids. Res. 18, 3587-3596.
50. Mudrak, I., Ogris, E., Rotheneder, H., and Wintersberger, E. (1994). Coordinated trans activation of DNA synthesis- and precursor-producing enzymes by polyomavirus large T antigen through interaction with the retinoblastoma protein. Mol. Cell Biol. 14, 1886-1892.
51. Mymryk, J.S., Lee, R.W., and Bayley, S.T. (1992). Ability of adeno-virus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein. Mol. Biol. Cell. 3, 1107-1115.
52. Nevins, J.R. (1994). Cell cycle targets of the DNA tumor viruses. Curr. Opin. Genet. Dev. 4, 130-134.
53. Novitch, B.G., Mulligan, G.J., Jacks, T., and Lassar, A.B. (1996). Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135, 441-456.
54. Olson, E.N., and Klein, W.H. (1994). bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8, 1-8.
55. Pan, H., and Griep, A.E. (1994). Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8, 1285-1299.
56. Pan, H., and Griep, A.E. (1995). Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev. 9, 2157-2169.
57. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U.S.A. 90, 8392-8396.
58. Rao, S.S., Chu, C., and Kohtz, D.S. (1994). Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell Biol. 14, 5259-5267.
59. Sakamuro, D., Eviner, V., Elliott, K.J., Showe, L., White, E., and Prendergast, G.C. (1995). c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11, 2411-2418.
60. Schneider, J.W., Gu, W., Zhu, L., Mahdavi, V., and Nadal Ginard, B. (1994). Reversal of terminal differentiation mediated by p107 in Rb-/-muscle cells. Science 264, 1467-1471.
61. Schwartz, L.M. (1992). Insect muscle as a model for programmed cell death. J. Neurobiol 23, 1312-1326.
62. Shan, B., and Lee, W.H. (1994). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell Biol. 14, 8166-8173.
63. Sherr, C.J., and Roberts, J.M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes. Dev. 9, 1149-1163.
64. Sofer-Levi, Y., and Resnitzky, D. (1996). Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene 13, 2431-2437.
65. Solary, E., Bertrand, R., Kohn, K.W., and Pommier, Y. (1993). Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood 81, 1359-1368.
66. Sorrentino, V., Pepperkok, R., Davis, R.L., Ansorge, W., and Philipson, L. (1990). Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature 345, 813-815.
67. Tafuri, A., and Andreeff, M. (1990). Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia 4, 826-834.
68. Tedesco, D., Caruso, M., Fischer Fantuzzi, L., and Vesco, C. (1995). The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up-regulation and is not exerted by transformation-competent cytoplasmic mutants. J. Virol. 69, 6947-6957.
69. Teodoro, J.G., Shore, G.C., and Branton P.E. (1995). Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene 11, 467-474.
70. Vaidya, T.B., Rhodes, S.J., Taparowsky, E.J., and Konieczny, S.F. (1989). Fibroblast growth factor and transforming growth factor beta repress transcription of the myogenic regulatory gene MyoD1. Mol. Cell Biol. 9, 3576-3579.
71. Wang, J., Guo, K., Wills, K.N., and Walsh, K. (1997). Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res. 57, 351-354.
72. Wang, J., and Nadal Ginard, B. (1995). Regulation of cyclins and p34CDC2 expression during terminal differentiation of C2C12 myocytes. Biochem. Biophys. Res. Commun. 206, 82-88.
73. Wang, J., and Walsh, K. (1996). Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273, 359-361.
74. Weintraub, H. (1993). The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75, 1241-1244.
75. White, E. (1994). Tumour biology. p53, guardian of Rb [news; comment]. Nature 371, 21-22.
76. Wright, W.E., Binder, M., and Funk, W. (1991). Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol. Cell Biol. 11, 4104-4110.
77. Yaffe, D., and Saxel, O. (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725-727.
78. Zacksenhaus, E., Jiang, Z., Chung, D., Marth, J.D., Phillips, R.A., and Gallie, B.L. (1996). pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10, 3051-3064.